| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Fc | 47 | 2023 | 537 | 9.370 |
Why?
|
| Intestinal Mucosa | 94 | 2024 | 3044 | 7.250 |
Why?
|
| Histocompatibility Antigens Class I | 49 | 2023 | 1361 | 6.550 |
Why?
|
| Natural Killer T-Cells | 27 | 2024 | 318 | 6.180 |
Why?
|
| Immunoglobulin G | 49 | 2023 | 4568 | 5.010 |
Why?
|
| Cell Adhesion Molecules | 25 | 2024 | 1613 | 4.400 |
Why?
|
| Antigens, CD1 | 38 | 2013 | 434 | 4.220 |
Why?
|
| Antigens, CD | 38 | 2024 | 4035 | 3.810 |
Why?
|
| Inflammatory Bowel Diseases | 52 | 2023 | 2442 | 3.800 |
Why?
|
| Paneth Cells | 22 | 2024 | 100 | 3.710 |
Why?
|
| Immunity, Mucosal | 25 | 2020 | 498 | 3.450 |
Why?
|
| Antigens, CD1d | 40 | 2024 | 225 | 3.430 |
Why?
|
| Unfolded Protein Response | 16 | 2024 | 239 | 2.960 |
Why?
|
| Endoplasmic Reticulum | 15 | 2017 | 1133 | 2.600 |
Why?
|
| Crohn Disease | 29 | 2023 | 2295 | 2.400 |
Why?
|
| Antigen Presentation | 24 | 2022 | 1251 | 2.370 |
Why?
|
| Colitis | 32 | 2024 | 1242 | 2.340 |
Why?
|
| Intestines | 33 | 2022 | 1909 | 2.250 |
Why?
|
| Immune System | 7 | 2024 | 800 | 2.190 |
Why?
|
| Carcinoembryonic Antigen | 13 | 2020 | 338 | 2.170 |
Why?
|
| Epithelial Cells | 40 | 2023 | 3703 | 2.130 |
Why?
|
| Antigen-Antibody Complex | 9 | 2020 | 513 | 2.100 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 4 | 2017 | 94 | 1.860 |
Why?
|
| Carrier Proteins | 18 | 2018 | 4939 | 1.820 |
Why?
|
| Mucous Membrane | 8 | 2023 | 659 | 1.720 |
Why?
|
| T-Lymphocytes | 51 | 2023 | 10266 | 1.600 |
Why?
|
| Colitis, Ulcerative | 19 | 2023 | 1926 | 1.550 |
Why?
|
| Animals | 242 | 2024 | 169285 | 1.470 |
Why?
|
| Mice | 172 | 2024 | 82049 | 1.380 |
Why?
|
| Lymphocyte Activation | 40 | 2022 | 5505 | 1.370 |
Why?
|
| Interleukins | 11 | 2024 | 796 | 1.360 |
Why?
|
| Immune Tolerance | 11 | 2022 | 2323 | 1.350 |
Why?
|
| Inflammation | 37 | 2024 | 10873 | 1.340 |
Why?
|
| Antigens | 11 | 2023 | 1443 | 1.280 |
Why?
|
| beta 2-Microglobulin | 12 | 2013 | 330 | 1.230 |
Why?
|
| Receptors, IgG | 11 | 2020 | 564 | 1.220 |
Why?
|
| Autoimmunity | 6 | 2022 | 1361 | 1.170 |
Why?
|
| Albumins | 5 | 2017 | 577 | 1.080 |
Why?
|
| Killer Cells, Natural | 21 | 2020 | 2211 | 1.070 |
Why?
|
| Metagenome | 9 | 2013 | 465 | 1.070 |
Why?
|
| Dendritic Cells | 21 | 2022 | 2747 | 1.040 |
Why?
|
| Autophagy | 15 | 2022 | 1351 | 1.020 |
Why?
|
| Antigen-Presenting Cells | 11 | 2019 | 960 | 1.010 |
Why?
|
| Immunity | 4 | 2019 | 1003 | 1.010 |
Why?
|
| Mice, Inbred C57BL | 70 | 2024 | 22380 | 1.000 |
Why?
|
| Mice, Knockout | 52 | 2024 | 14488 | 0.980 |
Why?
|
| Immunoglobulin Fc Fragments | 6 | 2018 | 287 | 0.960 |
Why?
|
| Ileitis | 5 | 2023 | 40 | 0.930 |
Why?
|
| Protein Transport | 19 | 2019 | 1951 | 0.930 |
Why?
|
| Receptors, Cytokine | 11 | 2011 | 258 | 0.860 |
Why?
|
| CD4-Positive T-Lymphocytes | 15 | 2023 | 4415 | 0.850 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2018 | 3740 | 0.820 |
Why?
|
| Thymus Gland | 7 | 2022 | 1266 | 0.820 |
Why?
|
| Listeriosis | 2 | 2021 | 147 | 0.790 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 15 | 2007 | 812 | 0.780 |
Why?
|
| Antigens, Differentiation | 11 | 2007 | 921 | 0.780 |
Why?
|
| Signal Transduction | 35 | 2024 | 23648 | 0.770 |
Why?
|
| Cross-Priming | 2 | 2012 | 75 | 0.770 |
Why?
|
| Immunoglobulin A | 4 | 2021 | 992 | 0.730 |
Why?
|
| Galactosylceramides | 5 | 2021 | 90 | 0.720 |
Why?
|
| Stress, Physiological | 7 | 2017 | 1408 | 0.720 |
Why?
|
| Humans | 276 | 2024 | 768171 | 0.710 |
Why?
|
| Mice, Inbred BALB C | 25 | 2018 | 6231 | 0.710 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2015 | 1801 | 0.700 |
Why?
|
| Gastroenterology | 5 | 2016 | 593 | 0.700 |
Why?
|
| T-Lymphocyte Subsets | 14 | 2016 | 1816 | 0.690 |
Why?
|
| Niemann-Pick Diseases | 1 | 2019 | 27 | 0.680 |
Why?
|
| Lipids | 9 | 2024 | 3345 | 0.670 |
Why?
|
| Th17 Cells | 3 | 2023 | 791 | 0.660 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 83 | 0.650 |
Why?
|
| Sphingomyelins | 1 | 2019 | 105 | 0.650 |
Why?
|
| Protein Binding | 21 | 2024 | 9343 | 0.650 |
Why?
|
| Receptors, Antigen, T-Cell | 16 | 2022 | 2568 | 0.650 |
Why?
|
| Immunologic Techniques | 1 | 2019 | 213 | 0.620 |
Why?
|
| Factor VIII | 2 | 2018 | 349 | 0.620 |
Why?
|
| Thromboplastin | 1 | 2020 | 289 | 0.610 |
Why?
|
| Interleukin-10 | 8 | 2018 | 1184 | 0.600 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2017 | 121 | 0.590 |
Why?
|
| Cell Polarity | 10 | 2011 | 639 | 0.580 |
Why?
|
| Crystallography, X-Ray | 2 | 2021 | 1951 | 0.580 |
Why?
|
| Hepatocytes | 7 | 2022 | 1247 | 0.580 |
Why?
|
| Gastrointestinal Tract | 7 | 2021 | 840 | 0.570 |
Why?
|
| Hemophilia A | 2 | 2018 | 359 | 0.570 |
Why?
|
| Epithelium | 16 | 2015 | 1607 | 0.570 |
Why?
|
| Health | 2 | 2012 | 398 | 0.570 |
Why?
|
| Autoimmune Diseases | 6 | 2019 | 2257 | 0.570 |
Why?
|
| Adaptive Immunity | 5 | 2020 | 733 | 0.560 |
Why?
|
| Cell Line | 44 | 2020 | 15602 | 0.560 |
Why?
|
| Homeostasis | 11 | 2021 | 3348 | 0.560 |
Why?
|
| Glycoproteins | 7 | 2008 | 2202 | 0.550 |
Why?
|
| Oxazoles | 1 | 2018 | 199 | 0.550 |
Why?
|
| Immunity, Innate | 10 | 2020 | 3080 | 0.550 |
Why?
|
| Cytokines | 26 | 2024 | 7452 | 0.540 |
Why?
|
| Receptors, Interleukin | 5 | 2024 | 243 | 0.530 |
Why?
|
| Symbiosis | 6 | 2021 | 297 | 0.530 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2004 | 859 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 19 | 2019 | 9262 | 0.520 |
Why?
|
| PPAR gamma | 3 | 2008 | 487 | 0.510 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 6 | 2011 | 195 | 0.510 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 221 | 0.510 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 508 | 0.510 |
Why?
|
| Dextran Sulfate | 11 | 2024 | 258 | 0.510 |
Why?
|
| Colon | 14 | 2021 | 1801 | 0.510 |
Why?
|
| Transcription Factors | 14 | 2023 | 12171 | 0.500 |
Why?
|
| Serotonin | 1 | 2020 | 1043 | 0.500 |
Why?
|
| Protein Isoforms | 9 | 2017 | 1715 | 0.500 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 610 | 0.490 |
Why?
|
| Disease Models, Animal | 36 | 2021 | 18349 | 0.490 |
Why?
|
| Placenta | 4 | 2019 | 1725 | 0.490 |
Why?
|
| Cytotoxicity, Immunologic | 13 | 2011 | 1353 | 0.490 |
Why?
|
| Intestine, Small | 10 | 2023 | 1217 | 0.490 |
Why?
|
| Intestinal Diseases | 3 | 2013 | 505 | 0.480 |
Why?
|
| Hypersensitivity | 6 | 2017 | 1172 | 0.470 |
Why?
|
| Interleukin-15 | 1 | 2015 | 186 | 0.470 |
Why?
|
| Ligands | 10 | 2014 | 3284 | 0.470 |
Why?
|
| Celiac Disease | 2 | 2015 | 820 | 0.470 |
Why?
|
| Interferon-gamma | 14 | 2012 | 3161 | 0.460 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2018 | 1966 | 0.460 |
Why?
|
| Leukotrienes | 1 | 2015 | 232 | 0.450 |
Why?
|
| Mice, Transgenic | 20 | 2023 | 9561 | 0.450 |
Why?
|
| Transcytosis | 5 | 2017 | 48 | 0.450 |
Why?
|
| Abetalipoproteinemia | 3 | 2012 | 16 | 0.440 |
Why?
|
| Models, Immunological | 3 | 2007 | 518 | 0.440 |
Why?
|
| Up-Regulation | 17 | 2017 | 4149 | 0.440 |
Why?
|
| Bacteria | 6 | 2012 | 2216 | 0.430 |
Why?
|
| Immunity, Active | 2 | 2013 | 58 | 0.420 |
Why?
|
| Ileum | 6 | 2023 | 558 | 0.410 |
Why?
|
| Heparin | 1 | 2020 | 1636 | 0.410 |
Why?
|
| Thiazolidinediones | 4 | 2008 | 461 | 0.410 |
Why?
|
| Protein Conformation | 6 | 2021 | 3956 | 0.400 |
Why?
|
| Membrane Proteins | 12 | 2021 | 7876 | 0.400 |
Why?
|
| Receptors, Interleukin-17 | 2 | 2023 | 82 | 0.400 |
Why?
|
| Reperfusion Injury | 3 | 2010 | 1039 | 0.400 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 1179 | 0.400 |
Why?
|
| Cysteine | 2 | 2015 | 897 | 0.390 |
Why?
|
| Macrophages | 10 | 2021 | 5802 | 0.390 |
Why?
|
| DNA-Binding Proteins | 11 | 2013 | 9617 | 0.380 |
Why?
|
| Immune System Diseases | 1 | 2014 | 253 | 0.380 |
Why?
|
| Caspase 3 | 1 | 2014 | 730 | 0.380 |
Why?
|
| Th2 Cells | 6 | 2008 | 1078 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2021 | 2846 | 0.380 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11677 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 12 | 2024 | 4355 | 0.370 |
Why?
|
| Enteritis | 3 | 2022 | 164 | 0.370 |
Why?
|
| Major Histocompatibility Complex | 8 | 2008 | 877 | 0.370 |
Why?
|
| Oxazolone | 7 | 2018 | 61 | 0.370 |
Why?
|
| Receptors, Virus | 1 | 2014 | 651 | 0.370 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2012 | 100 | 0.360 |
Why?
|
| Cell Membrane | 14 | 2009 | 3655 | 0.360 |
Why?
|
| Stem Cells | 8 | 2024 | 3538 | 0.360 |
Why?
|
| Placental Circulation | 1 | 2010 | 37 | 0.360 |
Why?
|
| Mucus | 3 | 2022 | 346 | 0.360 |
Why?
|
| Nod2 Signaling Adaptor Protein | 4 | 2011 | 86 | 0.350 |
Why?
|
| Liver | 14 | 2024 | 7578 | 0.350 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10478 | 0.350 |
Why?
|
| Gene Expression Regulation | 16 | 2016 | 11930 | 0.350 |
Why?
|
| Enterocytes | 1 | 2011 | 220 | 0.350 |
Why?
|
| Macaca fascicularis | 2 | 2019 | 912 | 0.340 |
Why?
|
| Protein Engineering | 3 | 2012 | 553 | 0.340 |
Why?
|
| Interleukin-12 | 5 | 2012 | 577 | 0.340 |
Why?
|
| Caco-2 Cells | 9 | 2023 | 367 | 0.340 |
Why?
|
| Intestinal Neoplasms | 3 | 2021 | 314 | 0.330 |
Why?
|
| NF-kappa B | 10 | 2023 | 2494 | 0.330 |
Why?
|
| Flow Cytometry | 13 | 2023 | 5902 | 0.320 |
Why?
|
| Bacterial Translocation | 2 | 2024 | 74 | 0.320 |
Why?
|
| Lymphoid Tissue | 4 | 2011 | 445 | 0.320 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2013 | 707 | 0.310 |
Why?
|
| B-Lymphocytes | 12 | 2021 | 4793 | 0.310 |
Why?
|
| Flagellin | 1 | 2009 | 124 | 0.310 |
Why?
|
| Tumor Escape | 1 | 2011 | 372 | 0.310 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 533 | 0.310 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2008 | 69 | 0.300 |
Why?
|
| Amino Acid Sequence | 22 | 2018 | 13422 | 0.300 |
Why?
|
| Bile | 2 | 2020 | 299 | 0.300 |
Why?
|
| Dogs | 7 | 2017 | 3845 | 0.300 |
Why?
|
| Transfection | 14 | 2008 | 5756 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 8648 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2022 | 18065 | 0.290 |
Why?
|
| Dimerization | 4 | 2014 | 887 | 0.290 |
Why?
|
| Hepatitis B, Chronic | 1 | 2012 | 413 | 0.290 |
Why?
|
| Protein Multimerization | 3 | 2021 | 966 | 0.290 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 138 | 0.290 |
Why?
|
| Digestive System | 2 | 2007 | 244 | 0.290 |
Why?
|
| Membrane Glycoproteins | 9 | 2011 | 3713 | 0.290 |
Why?
|
| Protein Subunits | 8 | 2006 | 943 | 0.290 |
Why?
|
| Mucositis | 1 | 2008 | 108 | 0.290 |
Why?
|
| Interferon Type I | 2 | 2011 | 569 | 0.290 |
Why?
|
| Receptors, IgE | 3 | 2014 | 375 | 0.290 |
Why?
|
| Serum Albumin | 2 | 2018 | 677 | 0.290 |
Why?
|
| HT29 Cells | 6 | 2020 | 189 | 0.290 |
Why?
|
| Immunity, Cellular | 8 | 2011 | 1561 | 0.280 |
Why?
|
| Genes, MHC Class I | 3 | 2001 | 235 | 0.280 |
Why?
|
| Bile Ducts | 3 | 2018 | 288 | 0.280 |
Why?
|
| Maternal-Fetal Exchange | 4 | 2018 | 454 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 13 | 2023 | 4648 | 0.280 |
Why?
|
| Germ-Free Life | 2 | 2021 | 187 | 0.280 |
Why?
|
| Tyrosine | 3 | 2012 | 1427 | 0.280 |
Why?
|
| Neoplasms | 8 | 2020 | 22371 | 0.280 |
Why?
|
| Microsomes | 1 | 2007 | 252 | 0.270 |
Why?
|
| Gastrointestinal Agents | 1 | 2012 | 511 | 0.270 |
Why?
|
| Bacteroides fragilis | 2 | 2021 | 250 | 0.270 |
Why?
|
| Cholangitis | 2 | 2018 | 110 | 0.270 |
Why?
|
| Stomach | 5 | 2011 | 701 | 0.270 |
Why?
|
| Cells, Cultured | 30 | 2020 | 19025 | 0.270 |
Why?
|
| Lung | 6 | 2017 | 10101 | 0.270 |
Why?
|
| Macrophages, Peritoneal | 2 | 2010 | 244 | 0.260 |
Why?
|
| Molecular Sequence Data | 28 | 2007 | 17623 | 0.260 |
Why?
|
| Clone Cells | 5 | 2004 | 1670 | 0.260 |
Why?
|
| Polysaccharides | 2 | 2012 | 1024 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 15 | 2015 | 6082 | 0.260 |
Why?
|
| Calnexin | 1 | 2005 | 23 | 0.260 |
Why?
|
| Colonic Neoplasms | 3 | 2020 | 2541 | 0.260 |
Why?
|
| Isomerases | 1 | 2005 | 55 | 0.250 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 1904 | 0.250 |
Why?
|
| Acetaminophen | 2 | 2022 | 552 | 0.250 |
Why?
|
| NFATC Transcription Factors | 3 | 2016 | 393 | 0.250 |
Why?
|
| Alternative Splicing | 2 | 2008 | 1105 | 0.250 |
Why?
|
| Career Choice | 1 | 2011 | 769 | 0.240 |
Why?
|
| Endoribonucleases | 4 | 2024 | 231 | 0.240 |
Why?
|
| Glycosylation | 3 | 2024 | 1100 | 0.240 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2008 | 977 | 0.240 |
Why?
|
| Immunologic Memory | 4 | 2014 | 1377 | 0.240 |
Why?
|
| Myeloid Cells | 2 | 2007 | 839 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 16044 | 0.230 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 117 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1205 | 0.230 |
Why?
|
| Immunotherapy | 5 | 2020 | 4754 | 0.230 |
Why?
|
| Male | 66 | 2024 | 364731 | 0.230 |
Why?
|
| Lysosomes | 5 | 2019 | 938 | 0.230 |
Why?
|
| Environment | 1 | 2010 | 1121 | 0.230 |
Why?
|
| Colorectal Neoplasms | 7 | 2016 | 6975 | 0.230 |
Why?
|
| Female | 64 | 2024 | 397187 | 0.230 |
Why?
|
| Genes, MHC Class II | 2 | 2023 | 433 | 0.220 |
Why?
|
| Minor Histocompatibility Antigens | 9 | 2011 | 303 | 0.220 |
Why?
|
| Lymphocyte Subsets | 3 | 1999 | 313 | 0.220 |
Why?
|
| Chlamydia | 1 | 2023 | 33 | 0.220 |
Why?
|
| Monocytes | 3 | 2020 | 2605 | 0.220 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 293 | 0.220 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2017 | 200 | 0.220 |
Why?
|
| Amino Acid Motifs | 4 | 2012 | 930 | 0.220 |
Why?
|
| Base Sequence | 18 | 2005 | 12422 | 0.220 |
Why?
|
| Acquired Immunodeficiency Syndrome | 8 | 2010 | 2204 | 0.220 |
Why?
|
| Interleukin-4 | 7 | 2018 | 1156 | 0.220 |
Why?
|
| Mast Cells | 4 | 2014 | 1406 | 0.220 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 1991 | 897 | 0.220 |
Why?
|
| Liver Diseases | 2 | 2023 | 1305 | 0.220 |
Why?
|
| Exocytosis | 1 | 2005 | 323 | 0.210 |
Why?
|
| Apoptosis | 11 | 2021 | 9527 | 0.210 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2010 | 880 | 0.210 |
Why?
|
| Cholera Toxin | 2 | 2005 | 562 | 0.210 |
Why?
|
| Asthma | 5 | 2016 | 6291 | 0.210 |
Why?
|
| Mice, Mutant Strains | 4 | 2021 | 1754 | 0.210 |
Why?
|
| Faculty, Medical | 1 | 2011 | 1226 | 0.210 |
Why?
|
| beta Catenin | 1 | 2008 | 1047 | 0.210 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2007 | 94 | 0.210 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2000 | 67 | 0.210 |
Why?
|
| Activating Transcription Factor 6 | 2 | 2020 | 31 | 0.210 |
Why?
|
| Gastric Mucosa | 3 | 2004 | 602 | 0.210 |
Why?
|
| Tumor Necrosis Factors | 2 | 2017 | 109 | 0.210 |
Why?
|
| Jurkat Cells | 5 | 2017 | 740 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 3610 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2649 | 0.200 |
Why?
|
| Down-Regulation | 6 | 2012 | 2939 | 0.200 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 326 | 0.200 |
Why?
|
| Awards and Prizes | 1 | 2006 | 365 | 0.190 |
Why?
|
| Staining and Labeling | 2 | 2019 | 1080 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2014 | 3447 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2018 | 2748 | 0.190 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 1793 | 0.190 |
Why?
|
| Carbohydrates | 2 | 2022 | 389 | 0.190 |
Why?
|
| Blotting, Western | 10 | 2016 | 5028 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 797 | 0.190 |
Why?
|
| Cell Communication | 2 | 2022 | 1660 | 0.190 |
Why?
|
| Cytoplasm | 4 | 2012 | 1505 | 0.190 |
Why?
|
| Goblet Cells | 4 | 2021 | 300 | 0.180 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 394 | 0.180 |
Why?
|
| Fluorometry | 1 | 2021 | 99 | 0.180 |
Why?
|
| Autocrine Communication | 2 | 2013 | 168 | 0.180 |
Why?
|
| Binding Sites | 5 | 2022 | 6019 | 0.180 |
Why?
|
| Antibody Formation | 4 | 2004 | 1393 | 0.180 |
Why?
|
| Infant, Newborn | 10 | 2023 | 26421 | 0.180 |
Why?
|
| RNA Interference | 3 | 2018 | 2832 | 0.180 |
Why?
|
| Enterochromaffin Cells | 1 | 2020 | 12 | 0.180 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2785 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7477 | 0.180 |
Why?
|
| Organoids | 3 | 2022 | 743 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 1470 | 0.180 |
Why?
|
| Cell Line, Tumor | 13 | 2020 | 17142 | 0.180 |
Why?
|
| Tryptophan | 2 | 2018 | 482 | 0.180 |
Why?
|
| Receptors, Immunologic | 5 | 2016 | 1418 | 0.180 |
Why?
|
| Lectins | 1 | 2022 | 490 | 0.180 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2000 | 81 | 0.180 |
Why?
|
| Erythropoietin | 2 | 2004 | 718 | 0.180 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2012 | 220 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 2 | 2005 | 999 | 0.180 |
Why?
|
| Autoantigens | 2 | 2022 | 890 | 0.170 |
Why?
|
| Antigens, Neoplasm | 3 | 2010 | 1996 | 0.170 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 253 | 0.170 |
Why?
|
| HSP110 Heat-Shock Proteins | 2 | 2014 | 10 | 0.170 |
Why?
|
| Pemphigus | 1 | 2021 | 107 | 0.170 |
Why?
|
| eIF-2 Kinase | 3 | 2019 | 147 | 0.170 |
Why?
|
| Diet | 1 | 2018 | 8089 | 0.170 |
Why?
|
| Platelet Factor 4 | 1 | 2020 | 132 | 0.170 |
Why?
|
| Th1 Cells | 6 | 2011 | 1042 | 0.170 |
Why?
|
| Peptide Fragments | 3 | 2009 | 5151 | 0.170 |
Why?
|
| Interleukin-13 | 3 | 2011 | 390 | 0.170 |
Why?
|
| HLA Antigens | 3 | 2007 | 1334 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 9 | 2015 | 6124 | 0.170 |
Why?
|
| HIV | 6 | 2014 | 1597 | 0.170 |
Why?
|
| Leukocytes | 5 | 2010 | 2034 | 0.160 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2018 | 167 | 0.160 |
Why?
|
| Endocytosis | 4 | 2017 | 957 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 1143 | 0.160 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2019 | 80 | 0.160 |
Why?
|
| Lymphocyte Count | 2 | 2019 | 794 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2009 | 1276 | 0.160 |
Why?
|
| Glycosphingolipids | 3 | 2019 | 73 | 0.160 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2021 | 267 | 0.160 |
Why?
|
| Salmonella typhi | 1 | 2020 | 200 | 0.160 |
Why?
|
| Antigens, Surface | 4 | 1999 | 1617 | 0.160 |
Why?
|
| Typhoid Fever | 1 | 2020 | 195 | 0.160 |
Why?
|
| Citrobacter rodentium | 2 | 2010 | 64 | 0.160 |
Why?
|
| Immunosuppressive Agents | 4 | 2006 | 4206 | 0.160 |
Why?
|
| Listeria monocytogenes | 2 | 2012 | 246 | 0.160 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2018 | 43 | 0.160 |
Why?
|
| Strongylida Infections | 1 | 2018 | 48 | 0.160 |
Why?
|
| DNA Primers | 7 | 2005 | 2828 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 5804 | 0.150 |
Why?
|
| Immunoglobulin E | 2 | 2015 | 1506 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2022 | 1151 | 0.150 |
Why?
|
| Purines | 1 | 2022 | 615 | 0.150 |
Why?
|
| Biotechnology | 1 | 2000 | 283 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 361 | 0.150 |
Why?
|
| Factor IX | 1 | 2018 | 76 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2015 | 3814 | 0.150 |
Why?
|
| Phagocytosis | 3 | 2021 | 1530 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 6 | 2013 | 3772 | 0.150 |
Why?
|
| Food Hypersensitivity | 2 | 2017 | 734 | 0.150 |
Why?
|
| Sepsis | 3 | 2024 | 2608 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 290 | 0.150 |
Why?
|
| Ovalbumin | 5 | 2017 | 677 | 0.150 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 623 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2020 | 547 | 0.140 |
Why?
|
| Phosphorylation | 6 | 2013 | 8316 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2010 | 2474 | 0.140 |
Why?
|
| Hemophilia B | 1 | 2018 | 83 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2018 | 3115 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2021 | 5402 | 0.140 |
Why?
|
| Oncostatin M | 1 | 2017 | 42 | 0.140 |
Why?
|
| Coculture Techniques | 5 | 2019 | 1344 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 684 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2011 | 2486 | 0.140 |
Why?
|
| Adenoviridae | 4 | 2012 | 1093 | 0.140 |
Why?
|
| Isoantibodies | 2 | 2018 | 681 | 0.140 |
Why?
|
| Acetylglucosamine | 1 | 2018 | 189 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2010 | 190 | 0.140 |
Why?
|
| Chemokines, CXC | 2 | 2014 | 420 | 0.140 |
Why?
|
| Common Bile Duct | 1 | 1997 | 106 | 0.140 |
Why?
|
| Infertility | 1 | 2023 | 655 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3056 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3428 | 0.140 |
Why?
|
| Bile Duct Diseases | 1 | 2017 | 98 | 0.130 |
Why?
|
| Nucleotidyltransferases | 1 | 2018 | 242 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 5 | 2010 | 1703 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2021 | 2121 | 0.130 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2016 | 15 | 0.130 |
Why?
|
| Dermatitis, Contact | 2 | 2008 | 134 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 5797 | 0.130 |
Why?
|
| Antigens, Bacterial | 2 | 2014 | 1150 | 0.130 |
Why?
|
| Immunomodulation | 2 | 2018 | 549 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1996 | 354 | 0.130 |
Why?
|
| Interleukin-17 | 3 | 2023 | 924 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 4 | 2014 | 874 | 0.130 |
Why?
|
| STAT Transcription Factors | 2 | 2018 | 189 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2011 | 3463 | 0.130 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1989 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2014 | 2596 | 0.130 |
Why?
|
| Protein Kinase C | 3 | 2016 | 1207 | 0.130 |
Why?
|
| Protein Folding | 2 | 2010 | 871 | 0.120 |
Why?
|
| Isoenzymes | 3 | 2016 | 1688 | 0.120 |
Why?
|
| Ion Channels | 1 | 2020 | 1043 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2016 | 101 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2019 | 599 | 0.120 |
Why?
|
| Interleukin-2 | 5 | 2013 | 1895 | 0.120 |
Why?
|
| Disease | 2 | 2013 | 675 | 0.120 |
Why?
|
| RNA, Messenger | 15 | 2011 | 12801 | 0.120 |
Why?
|
| Receptors, Cell Surface | 3 | 2011 | 2819 | 0.120 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1676 | 0.120 |
Why?
|
| Mucins | 2 | 2024 | 570 | 0.120 |
Why?
|
| Calcineurin | 1 | 2016 | 235 | 0.120 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 148 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2909 | 0.120 |
Why?
|
| Biological Assay | 1 | 2018 | 628 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2008 | 3074 | 0.120 |
Why?
|
| Mastocytosis | 1 | 2017 | 150 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2020 | 2982 | 0.120 |
Why?
|
| Natriuretic Peptides | 1 | 2016 | 156 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 1049 | 0.120 |
Why?
|
| Interleukin-23 | 2 | 2016 | 202 | 0.120 |
Why?
|
| U937 Cells | 3 | 2005 | 260 | 0.120 |
Why?
|
| Egg Hypersensitivity | 1 | 2014 | 47 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4280 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 539 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2018 | 549 | 0.110 |
Why?
|
| Chlamydia muridarum | 1 | 2014 | 10 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1247 | 0.110 |
Why?
|
| Receptors, Peptide | 1 | 2016 | 280 | 0.110 |
Why?
|
| Bacteriophages | 1 | 2017 | 382 | 0.110 |
Why?
|
| Spleen | 5 | 2017 | 2296 | 0.110 |
Why?
|
| Biological Transport | 5 | 2005 | 2085 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4249 | 0.110 |
Why?
|
| Arginine | 2 | 2004 | 932 | 0.110 |
Why?
|
| Perfusion | 1 | 2019 | 1401 | 0.110 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 2014 | 306 | 0.110 |
Why?
|
| Mutation | 10 | 2021 | 30237 | 0.110 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2013 | 4 | 0.110 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 355 | 0.110 |
Why?
|
| Receptors, Scavenger | 1 | 2014 | 123 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2010 | 565 | 0.110 |
Why?
|
| Pregnancy | 10 | 2019 | 30255 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2005 | 1134 | 0.110 |
Why?
|
| Streptococcus agalactiae | 1 | 1995 | 337 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2013 | 91 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1999 | 1730 | 0.110 |
Why?
|
| Cytomegalovirus | 2 | 2016 | 753 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2017 | 342 | 0.100 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 825 | 0.100 |
Why?
|
| Diet Therapy | 1 | 2014 | 150 | 0.100 |
Why?
|
| Penetrance | 1 | 2014 | 385 | 0.100 |
Why?
|
| Antibodies | 3 | 2019 | 2421 | 0.100 |
Why?
|
| Cytosol | 2 | 2017 | 887 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2021 | 3445 | 0.100 |
Why?
|
| Antigens, Viral | 2 | 1987 | 995 | 0.100 |
Why?
|
| Graft vs Host Disease | 2 | 2018 | 3049 | 0.100 |
Why?
|
| Protein Phosphatase 1 | 2 | 2004 | 135 | 0.100 |
Why?
|
| Precipitin Tests | 5 | 1999 | 816 | 0.100 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2012 | 30 | 0.100 |
Why?
|
| Animals, Newborn | 4 | 2014 | 2683 | 0.100 |
Why?
|
| Chemokine CXCL6 | 1 | 2012 | 14 | 0.100 |
Why?
|
| Allergens | 2 | 2017 | 1443 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 2810 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2011 | 247 | 0.100 |
Why?
|
| Research | 1 | 2001 | 1979 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1399 | 0.100 |
Why?
|
| Cloning, Molecular | 6 | 2005 | 4168 | 0.100 |
Why?
|
| Gene Deletion | 2 | 2017 | 2674 | 0.100 |
Why?
|
| Helicobacter heilmannii | 1 | 2011 | 6 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2014 | 588 | 0.100 |
Why?
|
| Interleukin-12 Subunit p35 | 2 | 2011 | 22 | 0.100 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.100 |
Why?
|
| Cell Survival | 5 | 2022 | 5789 | 0.100 |
Why?
|
| Chromans | 2 | 2002 | 116 | 0.100 |
Why?
|
| Thapsigargin | 2 | 2023 | 102 | 0.100 |
Why?
|
| Rats | 11 | 2010 | 23782 | 0.100 |
Why?
|
| Genes, RAG-1 | 2 | 2002 | 68 | 0.100 |
Why?
|
| DNA Damage | 1 | 2021 | 2469 | 0.090 |
Why?
|
| Antibodies, Bacterial | 3 | 2014 | 1478 | 0.090 |
Why?
|
| Graft vs Tumor Effect | 1 | 2011 | 68 | 0.090 |
Why?
|
| Herpesvirus 4, Human | 2 | 1987 | 1082 | 0.090 |
Why?
|
| Paracrine Communication | 2 | 2016 | 279 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2023 | 2401 | 0.090 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 294 | 0.090 |
Why?
|
| Immunohistochemistry | 11 | 2018 | 11095 | 0.090 |
Why?
|
| Neutrophils | 3 | 2020 | 3786 | 0.090 |
Why?
|
| Antibody Specificity | 4 | 2001 | 1065 | 0.090 |
Why?
|
| Feedback, Physiological | 2 | 2014 | 482 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 2 | 2011 | 598 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2004 | 458 | 0.090 |
Why?
|
| Adenoma | 1 | 2021 | 2159 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3782 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 1995 | 619 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2014 | 3214 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2004 | 567 | 0.090 |
Why?
|
| Immune System Phenomena | 1 | 2010 | 17 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 2004 | 0.090 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2014 | 205 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1754 | 0.090 |
Why?
|
| Mitochondria | 2 | 2023 | 3683 | 0.090 |
Why?
|
| Age of Onset | 2 | 2014 | 3346 | 0.090 |
Why?
|
| RNA | 1 | 2020 | 2722 | 0.090 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 365 | 0.090 |
Why?
|
| Apolipoproteins B | 1 | 2012 | 386 | 0.090 |
Why?
|
| Thiazoles | 4 | 2018 | 1542 | 0.090 |
Why?
|
| Interphase | 2 | 2002 | 227 | 0.090 |
Why?
|
| Diverticulitis | 3 | 1999 | 187 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2017 | 1096 | 0.090 |
Why?
|
| HIV Enteropathy | 1 | 2009 | 4 | 0.090 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2008 | 93 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2014 | 545 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2010 | 65 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 327 | 0.090 |
Why?
|
| Caveolins | 2 | 2000 | 102 | 0.090 |
Why?
|
| Phagosomes | 1 | 2011 | 198 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2012 | 338 | 0.080 |
Why?
|
| Solubility | 4 | 2006 | 1086 | 0.080 |
Why?
|
| Tryptases | 1 | 2010 | 176 | 0.080 |
Why?
|
| Models, Biological | 4 | 2011 | 9497 | 0.080 |
Why?
|
| Galectin 4 | 2 | 2012 | 36 | 0.080 |
Why?
|
| Lipopolysaccharides | 5 | 2014 | 2222 | 0.080 |
Why?
|
| Deltaretrovirus | 2 | 1986 | 162 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2020 | 3781 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2008 | 2766 | 0.080 |
Why?
|
| Cromolyn Sodium | 1 | 2009 | 78 | 0.080 |
Why?
|
| alpha-Defensins | 1 | 2008 | 30 | 0.080 |
Why?
|
| Organ Specificity | 5 | 2011 | 1968 | 0.080 |
Why?
|
| Molecular Weight | 4 | 2000 | 2173 | 0.080 |
Why?
|
| Antigens, Plant | 1 | 2009 | 104 | 0.080 |
Why?
|
| Cross-Linking Reagents | 3 | 2014 | 693 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2011 | 349 | 0.080 |
Why?
|
| Epitopes | 5 | 2009 | 2527 | 0.080 |
Why?
|
| HLA-DQ Antigens | 1 | 2009 | 190 | 0.080 |
Why?
|
| Simian immunodeficiency virus | 2 | 2014 | 814 | 0.080 |
Why?
|
| Azoxymethane | 1 | 2008 | 32 | 0.080 |
Why?
|
| Peritonitis | 2 | 2011 | 368 | 0.080 |
Why?
|
| Pedigree | 2 | 2014 | 4539 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2006 | 1648 | 0.080 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 128 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 2 | 2018 | 2709 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 110 | 0.080 |
Why?
|
| Cell Degranulation | 1 | 2009 | 277 | 0.080 |
Why?
|
| Helicobacter pylori | 1 | 2011 | 380 | 0.080 |
Why?
|
| Phospholipids | 1 | 2012 | 787 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 1354 | 0.070 |
Why?
|
| Helicobacter Infections | 1 | 2011 | 390 | 0.070 |
Why?
|
| Chemokines | 4 | 2010 | 963 | 0.070 |
Why?
|
| Jejunum | 3 | 2002 | 475 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2014 | 4120 | 0.070 |
Why?
|
| Esophagus | 1 | 2014 | 1042 | 0.070 |
Why?
|
| Transglutaminases | 1 | 2009 | 200 | 0.070 |
Why?
|
| Fetus | 3 | 2003 | 1883 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2014 | 1683 | 0.070 |
Why?
|
| Heterozygote | 1 | 2014 | 2798 | 0.070 |
Why?
|
| Lactobacillus | 1 | 2009 | 212 | 0.070 |
Why?
|
| Peroxisomes | 1 | 2008 | 67 | 0.070 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 6512 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.070 |
Why?
|
| Endosomes | 3 | 2019 | 522 | 0.070 |
Why?
|
| Melanoma, Experimental | 2 | 2008 | 559 | 0.070 |
Why?
|
| Bacterial Infections | 3 | 2004 | 1397 | 0.070 |
Why?
|
| T-Box Domain Proteins | 3 | 2008 | 472 | 0.070 |
Why?
|
| Communicable Diseases | 2 | 2007 | 873 | 0.070 |
Why?
|
| AIDS-Related Complex | 1 | 1987 | 107 | 0.070 |
Why?
|
| Endotoxemia | 1 | 2008 | 198 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2008 | 141 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 1988 | 175 | 0.070 |
Why?
|
| Disease Management | 1 | 2018 | 2535 | 0.070 |
Why?
|
| Genome, Human | 1 | 2000 | 4446 | 0.070 |
Why?
|
| Salmonella typhimurium | 1 | 2009 | 347 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 4786 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2022 | 348 | 0.070 |
Why?
|
| Calmodulin | 1 | 2007 | 241 | 0.070 |
Why?
|
| Sequence Alignment | 4 | 2005 | 2179 | 0.070 |
Why?
|
| Glutens | 1 | 2009 | 240 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 432 | 0.070 |
Why?
|
| Neurons | 1 | 2006 | 9514 | 0.070 |
Why?
|
| Proteins | 1 | 2001 | 6009 | 0.070 |
Why?
|
| Lymphocytes | 4 | 2005 | 2614 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2010 | 652 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 446 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 3 | 2016 | 837 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2008 | 365 | 0.070 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 446 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2005 | 515 | 0.070 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2005 | 14 | 0.070 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2007 | 301 | 0.060 |
Why?
|
| Child Development | 1 | 2017 | 2330 | 0.060 |
Why?
|
| Cryptosporidium parvum | 1 | 2005 | 35 | 0.060 |
Why?
|
| Premature Birth | 1 | 2018 | 1829 | 0.060 |
Why?
|
| Lysine | 1 | 1990 | 1000 | 0.060 |
Why?
|
| Leucine | 2 | 2004 | 547 | 0.060 |
Why?
|
| Feces | 2 | 2010 | 1511 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4913 | 0.060 |
Why?
|
| Hybridomas | 2 | 2005 | 444 | 0.060 |
Why?
|
| Cryptosporidiosis | 1 | 2005 | 52 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 1972 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2012 | 810 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12466 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 725 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 375 | 0.060 |
Why?
|
| Carbohydrate Conformation | 1 | 2005 | 206 | 0.060 |
Why?
|
| CHO Cells | 4 | 2002 | 1379 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2592 | 0.060 |
Why?
|
| Porphyromonas gingivalis | 1 | 2006 | 165 | 0.060 |
Why?
|
| Adult | 23 | 2021 | 223646 | 0.060 |
Why?
|
| Chlamydia trachomatis | 1 | 2007 | 239 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 624 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 2539 | 0.060 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2024 | 31 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3589 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 911 | 0.060 |
Why?
|
| Phenotype | 6 | 2018 | 16726 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 948 | 0.060 |
Why?
|
| Granuloma | 1 | 2007 | 329 | 0.060 |
Why?
|
| Antigens, Ly | 2 | 2004 | 297 | 0.060 |
Why?
|
| Organ Culture Techniques | 2 | 2017 | 796 | 0.060 |
Why?
|
| Coccidiosis | 1 | 1984 | 10 | 0.060 |
Why?
|
| Drug Approval | 1 | 2012 | 821 | 0.060 |
Why?
|
| Immunity, Maternally-Acquired | 2 | 2002 | 112 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2020 | 4850 | 0.060 |
Why?
|
| Absorption | 1 | 2004 | 244 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2005 | 705 | 0.060 |
Why?
|
| Genes, APC | 2 | 2016 | 145 | 0.060 |
Why?
|
| Cricetinae | 4 | 2002 | 2423 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 2009 | 0.060 |
Why?
|
| Calreticulin | 1 | 2005 | 115 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2007 | 760 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 6395 | 0.060 |
Why?
|
| Eosinophils | 2 | 2007 | 952 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2016 | 2346 | 0.060 |
Why?
|
| Obesity | 3 | 2024 | 13091 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 2006 | 393 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2023 | 15 | 0.060 |
Why?
|
| Immunization | 2 | 2018 | 1219 | 0.050 |
Why?
|
| Biotinylation | 1 | 2004 | 185 | 0.050 |
Why?
|
| Dehydroepiandrosterone | 1 | 2004 | 259 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 588 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2360 | 0.050 |
Why?
|
| Cholecystitis | 1 | 1984 | 181 | 0.050 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2005 | 211 | 0.050 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2005 | 137 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 1505 | 0.050 |
Why?
|
| Gingiva | 1 | 2006 | 423 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 1673 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1987 | 1854 | 0.050 |
Why?
|
| Antibodies, Blocking | 2 | 2018 | 250 | 0.050 |
Why?
|
| Disulfides | 1 | 2005 | 466 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 697 | 0.050 |
Why?
|
| Genitalia | 1 | 2023 | 114 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 1124 | 0.050 |
Why?
|
| Permeability | 1 | 2005 | 726 | 0.050 |
Why?
|
| Detergents | 2 | 2000 | 235 | 0.050 |
Why?
|
| Butyrates | 1 | 2023 | 167 | 0.050 |
Why?
|
| Staphylococcus aureus | 2 | 2009 | 1430 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 4620 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2892 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 1028 | 0.050 |
Why?
|
| Interleukin-1 | 2 | 2004 | 1252 | 0.050 |
Why?
|
| Multigene Family | 4 | 2001 | 1081 | 0.050 |
Why?
|
| Age Factors | 2 | 2017 | 18415 | 0.050 |
Why?
|
| Time Factors | 6 | 2008 | 40220 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2010 | 1068 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2002 | 249 | 0.050 |
Why?
|
| Galactosyltransferases | 1 | 2024 | 284 | 0.050 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3229 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 321 | 0.050 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 43 | 0.050 |
Why?
|
| Young Adult | 5 | 2021 | 60066 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 1984 | 235 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 440 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2022 | 2575 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2022 | 41 | 0.050 |
Why?
|
| Enterotoxins | 2 | 2000 | 366 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2013 | 1986 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2005 | 1760 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2004 | 564 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 246 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.050 |
Why?
|
| Mucin-2 | 1 | 2021 | 50 | 0.050 |
Why?
|
| Cell Culture Techniques | 4 | 2020 | 1667 | 0.050 |
Why?
|
| Urea | 1 | 2004 | 448 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2008 | 1207 | 0.050 |
Why?
|
| Azathioprine | 1 | 2003 | 354 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2002 | 136 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 577 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 411 | 0.050 |
Why?
|
| Gene Expression | 5 | 2005 | 7601 | 0.050 |
Why?
|
| Melanoma | 3 | 2006 | 5706 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2022 | 145 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 1987 | 966 | 0.050 |
Why?
|
| Macromolecular Substances | 4 | 1991 | 1435 | 0.050 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2000 | 19 | 0.050 |
Why?
|
| Kidney | 4 | 2017 | 7064 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2002 | 361 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2001 | 114 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2002 | 224 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 100 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2004 | 827 | 0.040 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 737 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1105 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 2014 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2002 | 241 | 0.040 |
Why?
|
| Muramidase | 1 | 2020 | 163 | 0.040 |
Why?
|
| Chemokines, CX3C | 1 | 2000 | 12 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2002 | 406 | 0.040 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2024 | 340 | 0.040 |
Why?
|
| DNA Probes | 1 | 2001 | 542 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2001 | 154 | 0.040 |
Why?
|
| Child | 8 | 2023 | 80917 | 0.040 |
Why?
|
| Half-Life | 2 | 2014 | 651 | 0.040 |
Why?
|
| Centrifugation | 1 | 2000 | 122 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 1319 | 0.040 |
Why?
|
| Granulocytes | 2 | 2016 | 551 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2002 | 301 | 0.040 |
Why?
|
| Viral Load | 1 | 2009 | 3396 | 0.040 |
Why?
|
| Capital Financing | 1 | 2000 | 58 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2002 | 251 | 0.040 |
Why?
|
| G(M1) Ganglioside | 1 | 2000 | 87 | 0.040 |
Why?
|
| Resuscitation | 1 | 2024 | 679 | 0.040 |
Why?
|
| Endothelium, Lymphatic | 1 | 2000 | 63 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2002 | 2627 | 0.040 |
Why?
|
| Immunization, Passive | 2 | 2014 | 619 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2001 | 370 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1524 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 892 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3590 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4585 | 0.040 |
Why?
|
| Immunoglobulins | 2 | 2003 | 855 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 1999 | 45 | 0.040 |
Why?
|
| Education, Medical | 1 | 2011 | 1742 | 0.040 |
Why?
|
| Adolescent | 7 | 2021 | 89169 | 0.040 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2019 | 108 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2009 | 3474 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.040 |
Why?
|
| Glucose | 2 | 2024 | 4352 | 0.040 |
Why?
|
| Escherichia coli | 2 | 2009 | 4213 | 0.040 |
Why?
|
| Immune Sera | 2 | 2006 | 605 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2020 | 211 | 0.040 |
Why?
|
| Nematospiroides dubius | 1 | 2018 | 37 | 0.040 |
Why?
|
| Plasmids | 1 | 2004 | 2269 | 0.040 |
Why?
|
| HIV Antibodies | 3 | 2014 | 1341 | 0.040 |
Why?
|
| Living Donors | 1 | 2023 | 647 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 542 | 0.040 |
Why?
|
| Integrin beta Chains | 1 | 2018 | 115 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 306 | 0.040 |
Why?
|
| Pyrans | 1 | 2018 | 49 | 0.040 |
Why?
|
| Fetal Blood | 2 | 2015 | 1361 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2018 | 118 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2000 | 1441 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2004 | 4492 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 648 | 0.040 |
Why?
|
| Industry | 1 | 2000 | 362 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 1988 | 1960 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 1998 | 139 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2018 | 163 | 0.040 |
Why?
|
| Rabbits | 1 | 2004 | 4773 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1999 | 420 | 0.040 |
Why?
|
| Genetic Variation | 5 | 2018 | 6610 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2414 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2012 | 4428 | 0.040 |
Why?
|
| Cell Separation | 2 | 2003 | 1728 | 0.040 |
Why?
|
| Respiration | 1 | 2004 | 1665 | 0.040 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1997 | 46 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 4363 | 0.040 |
Why?
|
| Knee Joint | 1 | 2006 | 1683 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2004 | 774 | 0.040 |
Why?
|
| Chemotaxis | 2 | 2014 | 600 | 0.030 |
Why?
|
| Temperature | 1 | 2004 | 2234 | 0.030 |
Why?
|
| Cell Death | 1 | 2022 | 1680 | 0.030 |
Why?
|
| Middle Aged | 11 | 2021 | 223487 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 41753 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2001 | 3097 | 0.030 |
Why?
|
| Leadership | 1 | 2006 | 1397 | 0.030 |
Why?
|
| Financing, Government | 1 | 2000 | 473 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2000 | 794 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2007 | 59 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1997 | 240 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1996 | 64 | 0.030 |
Why?
|
| HIV Antigens | 2 | 1987 | 328 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 521 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1988 | 2334 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2021 | 9384 | 0.030 |
Why?
|
| Biopsy | 2 | 2020 | 6792 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 294 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2002 | 2430 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3803 | 0.030 |
Why?
|
| Retroviridae Infections | 2 | 1986 | 148 | 0.030 |
Why?
|
| United States | 4 | 2012 | 73039 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2014 | 2363 | 0.030 |
Why?
|
| K562 Cells | 1 | 2017 | 644 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2122 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 146 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 405 | 0.030 |
Why?
|
| Models, Structural | 1 | 1995 | 340 | 0.030 |
Why?
|
| Cell Migration Assays | 1 | 2014 | 22 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1998 | 958 | 0.030 |
Why?
|
| Administration, Rectal | 1 | 2014 | 69 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 1996 | 472 | 0.030 |
Why?
|
| Papain | 1 | 2014 | 66 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 309 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2024 | 1515 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1996 | 447 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1758 | 0.030 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2014 | 96 | 0.030 |
Why?
|
| Antioxidants | 1 | 2002 | 1676 | 0.030 |
Why?
|
| Calcium | 1 | 2007 | 5792 | 0.030 |
Why?
|
| Sirolimus | 1 | 2021 | 1540 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 551 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2002 | 3403 | 0.030 |
Why?
|
| Acute Disease | 2 | 2002 | 7243 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 1662 | 0.030 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 69 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2006 | 3968 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65379 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2014 | 252 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 2013 | 59 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2007 | 874 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 2013 | 108 | 0.030 |
Why?
|
| Aspirin | 1 | 2005 | 3135 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1904 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 1994 | 479 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 147 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2000 | 1058 | 0.030 |
Why?
|
| Hemagglutinins | 1 | 2013 | 111 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1998 | 1117 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 199 | 0.030 |
Why?
|
| Rats, Inbred Lew | 3 | 2002 | 1163 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8743 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 2237 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1752 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2012 | 58 | 0.030 |
Why?
|
| Hypoglycemic Agents | 2 | 2002 | 3109 | 0.030 |
Why?
|
| Microscopy | 1 | 2017 | 909 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2002 | 1893 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12795 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1162 | 0.020 |
Why?
|
| Isoantigens | 1 | 1994 | 562 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 1027 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 1216 | 0.020 |
Why?
|
| HIV-1 | 1 | 2009 | 6963 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1997 | 1864 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2014 | 563 | 0.020 |
Why?
|
| Glycolipids | 2 | 2005 | 205 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 2004 | 88 | 0.020 |
Why?
|
| Fas Ligand Protein | 2 | 2006 | 217 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1810 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2945 | 0.020 |
Why?
|
| Reference Values | 1 | 1999 | 4939 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2013 | 300 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 205 | 0.020 |
Why?
|
| Virus Diseases | 2 | 1990 | 724 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13586 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6894 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2012 | 90 | 0.020 |
Why?
|
| Piperidines | 1 | 2020 | 1667 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 417 | 0.020 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2011 | 88 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2014 | 404 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2956 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2007 | 22290 | 0.020 |
Why?
|
| Porins | 1 | 2010 | 78 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 1791 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2011 | 252 | 0.020 |
Why?
|
| Biodiversity | 1 | 2013 | 345 | 0.020 |
Why?
|
| Influenza, Human | 2 | 2016 | 1541 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 217 | 0.020 |
Why?
|
| Random Allocation | 2 | 2012 | 2395 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2004 | 3301 | 0.020 |
Why?
|
| GPI-Linked Proteins | 2 | 2004 | 472 | 0.020 |
Why?
|
| Virus Replication | 2 | 2016 | 2458 | 0.020 |
Why?
|
| Peroxidase | 2 | 2005 | 610 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2521 | 0.020 |
Why?
|
| Cell Movement | 2 | 2014 | 5213 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 573 | 0.020 |
Why?
|
| Cancer Vaccines | 2 | 2010 | 1040 | 0.020 |
Why?
|
| Homosexuality | 2 | 1987 | 269 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 92 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1993 | 2300 | 0.020 |
Why?
|
| Rectum | 1 | 2014 | 900 | 0.020 |
Why?
|
| Myosin Type V | 1 | 2009 | 33 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2016 | 2204 | 0.020 |
Why?
|
| Biliverdine | 1 | 2008 | 28 | 0.020 |
Why?
|
| Bloodletting | 1 | 1988 | 22 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2013 | 4034 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2094 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2010 | 297 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 383 | 0.020 |
Why?
|
| Caveolin 1 | 2 | 2000 | 255 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 693 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2018 | 2123 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2010 | 272 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2017 | 42669 | 0.020 |
Why?
|
| GATA6 Transcription Factor | 1 | 2008 | 54 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 393 | 0.020 |
Why?
|
| Immunologic Surveillance | 1 | 2008 | 93 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 1351 | 0.020 |
Why?
|
| Proviruses | 1 | 2009 | 320 | 0.020 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 1297 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 753 | 0.020 |
Why?
|
| HIV Infections | 1 | 2014 | 17569 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 2003 | 165 | 0.020 |
Why?
|
| Lactation | 1 | 2010 | 392 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 2065 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2008 | 125 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2011 | 4834 | 0.020 |
Why?
|
| STAT4 Transcription Factor | 1 | 2007 | 94 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 404 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1906 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 866 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2007 | 146 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1494 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 3556 | 0.020 |
Why?
|
| Rats, Inbred WF | 2 | 1998 | 140 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2062 | 0.020 |
Why?
|
| Rats, Inbred BN | 2 | 1999 | 231 | 0.020 |
Why?
|
| Thymidine | 1 | 1987 | 297 | 0.020 |
Why?
|
| Vitamin D | 1 | 2020 | 3311 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Integrins | 1 | 2011 | 842 | 0.020 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2006 | 67 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2007 | 267 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 201 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2007 | 262 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 474 | 0.020 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2007 | 120 | 0.020 |
Why?
|
| Aged | 7 | 2021 | 171502 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 1379 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1997 | 4178 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 478 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6525 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2009 | 504 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1986 | 223 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2008 | 806 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2008 | 560 | 0.020 |
Why?
|
| Survivors | 1 | 2016 | 2381 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2007 | 475 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1998 | 3007 | 0.020 |
Why?
|
| Leishmania major | 1 | 2005 | 60 | 0.020 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2004 | 30 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2004 | 190 | 0.020 |
Why?
|
| RNA Caps | 1 | 2005 | 73 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 2005 | 131 | 0.010 |
Why?
|
| Rubella | 1 | 1985 | 55 | 0.010 |
Why?
|
| Leprosy | 1 | 1985 | 125 | 0.010 |
Why?
|
| Parasitic Diseases | 1 | 1985 | 76 | 0.010 |
Why?
|
| Coccidia | 1 | 1984 | 2 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 204 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 693 | 0.010 |
Why?
|
| Bacteremia | 1 | 2011 | 985 | 0.010 |
Why?
|
| Chickenpox | 1 | 1985 | 95 | 0.010 |
Why?
|
| Metalloproteases | 1 | 2004 | 60 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 424 | 0.010 |
Why?
|
| Mumps | 1 | 1985 | 71 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 240 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2005 | 240 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 216 | 0.010 |
Why?
|
| Antiviral Agents | 2 | 1987 | 3072 | 0.010 |
Why?
|
| Bystander Effect | 1 | 2004 | 89 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1339 | 0.010 |
Why?
|
| Gangrene | 1 | 1984 | 92 | 0.010 |
Why?
|
| Vero Cells | 1 | 2005 | 485 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2012 | 1812 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8142 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2005 | 199 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15869 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 59626 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 105 | 0.010 |
Why?
|
| Antigens, Protozoan | 1 | 2005 | 315 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2004 | 439 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6229 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2004 | 491 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 669 | 0.010 |
Why?
|
| Infant | 2 | 2017 | 36535 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3806 | 0.010 |
Why?
|
| Dermatitis | 1 | 2005 | 203 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1987 | 1609 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1986 | 738 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2005 | 704 | 0.010 |
Why?
|
| Measles | 1 | 1985 | 180 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2007 | 910 | 0.010 |
Why?
|
| Employment | 1 | 1989 | 1110 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 7213 | 0.010 |
Why?
|
| Amides | 1 | 2005 | 452 | 0.010 |
Why?
|
| Gallbladder | 1 | 1984 | 308 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4543 | 0.010 |
Why?
|
| Peptides | 1 | 1994 | 4354 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 1985 | 252 | 0.010 |
Why?
|
| Graft Survival | 2 | 2004 | 3887 | 0.010 |
Why?
|
| Sheep | 1 | 2005 | 1451 | 0.010 |
Why?
|
| Haiti | 1 | 1984 | 553 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 319 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 1990 | 1014 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 317 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2003 | 250 | 0.010 |
Why?
|
| Mycoses | 1 | 1985 | 386 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1985 | 470 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2005 | 582 | 0.010 |
Why?
|
| Chloroquine | 1 | 1982 | 276 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 13045 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 594 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2004 | 841 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1892 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2885 | 0.010 |
Why?
|
| Antibody Diversity | 1 | 2000 | 72 | 0.010 |
Why?
|
| Serine | 1 | 2004 | 831 | 0.010 |
Why?
|
| Risk Factors | 3 | 2017 | 74944 | 0.010 |
Why?
|
| Superantigens | 1 | 2000 | 124 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12077 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 1625 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 164 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 2000 | 62 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1743 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4505 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1999 | 114 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 412 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2682 | 0.010 |
Why?
|
| Lymphoma | 1 | 2009 | 1898 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 530 | 0.010 |
Why?
|
| Cricetulus | 1 | 2001 | 812 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2634 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2000 | 318 | 0.010 |
Why?
|
| Receptors, HIV | 1 | 2000 | 159 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1985 | 711 | 0.010 |
Why?
|
| Mink | 1 | 1999 | 31 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2005 | 1197 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2000 | 574 | 0.010 |
Why?
|
| Body Weight | 1 | 2010 | 4627 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2005 | 936 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13290 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 991 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1255 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1999 | 401 | 0.010 |
Why?
|
| Erysipelothrix Infections | 1 | 1977 | 4 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 27362 | 0.010 |
Why?
|
| Disease Progression | 2 | 2007 | 13668 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 752 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1999 | 2087 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14783 | 0.010 |
Why?
|
| Recurrence | 1 | 1990 | 8509 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1997 | 130 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 660 | 0.010 |
Why?
|
| Perforin | 1 | 1997 | 167 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14729 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4477 | 0.010 |
Why?
|
| Granzymes | 1 | 1997 | 277 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 30009 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1996 | 348 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 5997 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2149 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2000 | 922 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12840 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 13490 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2002 | 1409 | 0.010 |
Why?
|
| Regeneration | 1 | 2002 | 1524 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 2857 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20225 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1977 | 436 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1993 | 510 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1982 | 1741 | 0.010 |
Why?
|
| Malaria | 1 | 1982 | 1249 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13677 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10763 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1997 | 1146 | 0.010 |
Why?
|
| Tuberculosis | 1 | 1985 | 2029 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7609 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 4790 | 0.010 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1990 | 29 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1990 | 61 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 283 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54924 | 0.010 |
Why?
|
| Pneumonia | 1 | 2001 | 2163 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1989 | 11519 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1989 | 1553 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1996 | 2934 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 4528 | 0.000 |
Why?
|
| Serotyping | 1 | 1987 | 331 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1987 | 655 | 0.000 |
Why?
|
| Vaccinia virus | 1 | 1987 | 328 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 12252 | 0.000 |
Why?
|
| Work Schedule Tolerance | 1 | 1989 | 553 | 0.000 |
Why?
|
| Zidovudine | 1 | 1987 | 625 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1989 | 1667 | 0.000 |
Why?
|
| Genes | 1 | 1987 | 1824 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1998 | 4262 | 0.000 |
Why?
|
| Meningocele | 1 | 1963 | 50 | 0.000 |
Why?
|
| Lymphokines | 1 | 1986 | 925 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1961 | 146 | 0.000 |
Why?
|
| Meningomyelocele | 1 | 1963 | 182 | 0.000 |
Why?
|
| Exercise Test | 1 | 1989 | 2186 | 0.000 |
Why?
|
| Spinal Dysraphism | 1 | 1963 | 179 | 0.000 |
Why?
|
| Kenya | 1 | 1982 | 757 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1982 | 830 | 0.000 |
Why?
|
| Travel | 1 | 1982 | 805 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1989 | 5536 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1982 | 1554 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 8052 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1961 | 1398 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 1 | 1977 | 1468 | 0.000 |
Why?
|
| Algorithms | 1 | 1989 | 14164 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1977 | 1970 | 0.000 |
Why?
|
| Incidence | 1 | 1963 | 21538 | 0.000 |
Why?
|